PRESS RELEASE published on 09/17/2026 at 07:00, 9 days 5 hours ago Informations privilégiées / Autres communiqués
PRESS RELEASE published on 09/17/2026 at 07:00, 9 days 5 hours ago Inside Information / Other news releases
BRIEF published on 09/16/2026 at 22:05, 9 days 14 hours ago Innate Pharma et Sobi officialisent leur partenariat Partenariat Stratégique Innate Pharma Phase 3 TELLOMAK-3 Sobi Lymphomes T
BRIEF published on 09/16/2026 at 22:05, 9 days 14 hours ago Innate Pharma and Sobi Partnership Becomes Effective Innate Pharma Lacutamab Sobi Partnership TELLOMAK-3 Study T-cell Lymphoma
BRIEF published on 09/16/2026 at 22:05, 9 days 14 hours ago Le partenariat entre Innate Pharma et Sobi entre en vigueur Innate Pharma Lacutamab Partenariat Sobi Étude TELLOMAK-3 Lymphome À Cellules T
BRIEF published on 09/16/2026 at 22:05, 9 days 14 hours ago Innate Pharma and Sobi formalize their partnership Strategic Partnership Innate Pharma Phase 3 TELLOMAK-3 Sobi T-cell Lymphomas
PRESS RELEASE published on 09/16/2026 at 22:00, 9 days 14 hours ago Inside Information / Other news releases Innate Pharma and Sobi partnership becomes effective after meeting closing conditions, triggering USD 75 million payment and commencing TELLOMAK-3 Phase 3 study in Q1 2027 Partnership Innate Pharma Closing Conditions Sobi TELLOMAK-3
PRESS RELEASE published on 09/16/2026 at 22:00, 9 days 14 hours ago Informations privilégiées / Autres communiqués Innate Pharma et Sobi confirment leur partenariat pour le développement de lacutamab dans les lymphomes T, marque le lancement de l’étude confirmatoire de Phase 3 TELLOMAK-3 Innate Pharma Lacutamab Phase 3 TELLOMAK-3 Sobi Lymphomes T
BRIEF published on 09/10/2026 at 07:05, 16 days 5 hours ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
BRIEF published on 09/10/2026 at 07:05, 16 days 5 hours ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
Published on 09/26/2026 at 01:00, 11 hours 11 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 11 hours 11 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 13 hours 56 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 18 hours 41 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 21 hours 11 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 07:45, 4 hours 26 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 12 hours 10 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 17 hours 41 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 18 hours 11 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:45, 18 hours 26 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 18 hours 31 minutes ago Availability of the 2026 half-year financial report
